Literature DB >> 21057971

Factors affecting management decisions in rectal cancer in clinical practice: results from a national survey.

A Habr-Gama1, R O Perez, G P São Julião, I Proscurshim, S C Nahas, J Gama-Rodrigues.   

Abstract

BACKGROUND: Management of rectal cancer has become increasingly complex and a multidisciplinary approach is considered of key importance for improving outcomes. A national survey among specialists involved in this multidisciplinary setting was performed.
METHODS: A web-based survey containing 11 questions regarding rectal cancer management was sent to surgeons and medical oncologists registered by their corresponding societies as members. Statistical analysis was performed using the chi-square and Fisher's exact tests for all categorical variables according to response to individual questions. Multivariate analysis was performed using Cox's logistic regression.
RESULTS: Overall, 418 email recipients responded the survey. Local staging was performed without either magnetic resonance imaging or endorectal ultrasound by 64% of responders. Seventy-two percent considered that final management decision should be made after neoadjuvant chemoradiation therapy. Additionally, 46% considered that an alternative procedure (local excision or observation) was appropriate in a patient with a complete clinical response. Colorectal surgeons were more frequently in favor of longer intervals after completion of chemoradiation therapy (P = 0.001) and of alternative management procedures after a complete clinical response (P = 0.02). After multivariate analysis, the choice of a watch and wait approach after a complete clinical response following neoadjuvant chemoradiation therapy was significantly more frequent among surgeons (OR 3.5, 95% CI 1.8-7.1).
CONCLUSIONS: Surgeons seem to be more in favor of tailoring management of rectal cancer according to tumor response after neoadjuvant chemoradiation therapy, with longer intervals after chemoradiation therapy, decisions about treatment strategy being made after chemoradiation therapy instead of before, and the use of alternative surgical procedures after a complete clinical response following neoadjuvant therapy.

Entities:  

Mesh:

Year:  2010        PMID: 21057971     DOI: 10.1007/s10151-010-0655-3

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  20 in total

1.  Local excision of rectal cancer revisited: ACOSOG protocol Z6041.

Authors:  David M Ota; Heidi Nelson
Journal:  Ann Surg Oncol       Date:  2006-11-14       Impact factor: 5.344

Review 2.  Complete clinical response after preoperative chemoradiation in rectal cancer: is a "wait and see" policy justified?

Authors:  R Glynne-Jones; M Wallace; J I L Livingstone; J Meyrick-Thomas
Journal:  Dis Colon Rectum       Date:  2007-11-28       Impact factor: 4.585

3.  Low rectal cancer: a call for a change of approach in abdominoperineal resection.

Authors:  Iris D Nagtegaal; Cornelius J H van de Velde; Corrie A M Marijnen; Jan H J M van Krieken; Philip Quirke
Journal:  J Clin Oncol       Date:  2005-12-20       Impact factor: 44.544

4.  Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: comparison with histologic findings.

Authors:  G F Gualdi; E Casciani; A Guadalaxara; C d'Orta; E Polettini; G Pappalardo
Journal:  Dis Colon Rectum       Date:  2000-03       Impact factor: 4.585

5.  The clinical staging of rectal cancer.

Authors:  R J Nicholls; A Y Mason; B C Morson; A K Dixon; I K Fry
Journal:  Br J Surg       Date:  1982-07       Impact factor: 6.939

6.  Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.

Authors:  Jose G Guillem; David B Chessin; Alfred M Cohen; Jinru Shia; Madhu Mazumdar; Warren Enker; Philip B Paty; Martin R Weiser; David Klimstra; Leonard Saltz; Bruce D Minsky; W Douglas Wong
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

7.  Practice parameters for the management of rectal cancer (revised).

Authors:  Joe J Tjandra; John W Kilkenny; W Donald Buie; Neil Hyman; Clifford Simmang; Thomas Anthony; Charles Orsay; James Church; Daniel Otchy; Jeffrey Cohen; Ronald Place; Frederick Denstman; Jan Rakinic; Richard Moore; Mark Whiteford
Journal:  Dis Colon Rectum       Date:  2005-03       Impact factor: 4.585

8.  Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging.

Authors:  G Brown; A G Radcliffe; R G Newcombe; N S Dallimore; M W Bourne; G T Williams
Journal:  Br J Surg       Date:  2003-03       Impact factor: 6.939

Review 9.  Multidisciplinary management of patients with advanced rectal cancer.

Authors:  Robert W Beart
Journal:  Clin Cancer Res       Date:  2007-11-15       Impact factor: 12.531

10.  CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II.

Authors:  E A Zerhouni; C Rutter; S R Hamilton; D M Balfe; A J Megibow; I R Francis; A A Moss; J P Heiken; C M Tempany; A M Aisen; J C Weinreb; C Gatsonis; B J McNeil
Journal:  Radiology       Date:  1996-08       Impact factor: 11.105

View more
  6 in total

1.  Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses.

Authors:  Stephanie Nougaret; Hebert Alberto Vargas; Yulia Lakhman; Romain Sudre; Richard K G Do; Frederic Bibeau; David Azria; Eric Assenat; Nicolas Molinari; Marie-Ange Pierredon; Philippe Rouanet; Boris Guiu
Journal:  Radiology       Date:  2016-02-26       Impact factor: 11.105

2.  Changing operative strategy from abdominoperineal resection to sphincter preservation in T3 low rectal cancer after downstaging by neoadjuvant chemoradiation: a preliminary report.

Authors:  Khaled M Madbouly; Ahmed M Hussein
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

3.  Management of distal rectal cancer: results from a national survey.

Authors:  G Melotti; E De Antoni; A Habr-Gama; A Minicozzi
Journal:  Updates Surg       Date:  2013-01-19

4.  Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer: A Multicenter Comparative Cross-Sectional Study with Rectal Preservation as Supported by Surgeon.

Authors:  Kwang-Seop Song; Sung Chan Park; Dae Kyung Sohn; Jae Hwan Oh; Min Jung Kim; Ji Won Park; Seung-Bum Ryoo; Seung-Yong Jeong; Kyu Joo Park; Heung-Kwon Oh; Duck-Woo Kim; Sung-Bum Kang
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

5.  Transanal minimally invasive surgery (TAMIS) using a new disposable device: our initial experience.

Authors:  G Sevá-Pereira; V L Trombeta; L G Capochim Romagnolo
Journal:  Tech Coloproctol       Date:  2013-06-06       Impact factor: 3.781

6.  Current Status of "Watch-and-Wait" Rectal Cancer Treatment in Asia-Pacific Countries.

Authors:  Jung Wook Huh; Kotaro Maeda; Zheng Liu; Xishan Wang; April Camilla Roslani; Woo Yong Lee
Journal:  Ann Coloproctol       Date:  2020-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.